{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:40:46Z","timestamp":1790044846836,"version":"4.0.1"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypercoagulability is a prominent feature of coronavirus disease 2019 (COVID-19) and can lead to fatal consequences. Although the impact of COVID-19 on several disorders is well-established, its effect on congenital bleeding disorders (CBDs) is not well-documented. To address this ambiguity, a systematic review was conducted on the available studies to determine the impact of COVID-19 and vaccination aimed to prevent COVID-19 on patients with CBDs. We performed a systematic literature review using relevant keywords and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) protocol. We conducted our search on the PubMed, Scopus, and Web of Science databases until July 2023. Out of 31 included studies, 12 case series covering 770 patients with CBD and COVID-19 were further analyzed. The majority of the patients had hemophilia A (n\u2009=\u2009352, \u223c46%) or hemophilia B (n\u2009=\u200974, \u223c10%), while the remaining patients had von Willebrand disease (n\u2009=\u200943, 5.6%) or rare bleeding disorders (n\u2009=\u200927, 3.5%). A total of 25 deaths (3.2%) and 22 intensive care unit admissions (2.8%) were recorded. Bleeding complications were reported in the majority of the 12 case series (n\u2009=\u20097, 58.3%) and in most of the case reports (n\u2009=\u20098, \u223c57%), while thrombotic complications were only reported in two studies (16.6%). The mortality rate ranged from 0% in five studies (41.6%) to 5.7% and the rate of hospitalization ranged from 0 to 40%. Bleeding complications were reported in a range of 0 to 81%, while the thrombotic complication rate in one study was 6.9%. The mortality rate varied from 0 to 5.7%, and the hospitalization rate ranged from 0 to 40%. Bleeding complications were reported in a range of 0 to 81%, while the rate of thrombotic complications in one study was 6.9%. Vaccination was reported in five case series, which included 821 patients with CBDs with the majority having hemophilia A (n\u2009=\u2009479; 67.2%) and hemophilia B (n\u2009=\u200985; \u223c12%). The most frequently reported side effects were myalgia (6.5%), flu-like symptoms (4.8%), fever (4.7%), and headache (4%). COVID-19 in patients with CBDs appears to provoke thrombotic complications and bleeding events more frequently, as well as a higher rate of hospitalization, which may be partially due to the increased risk of bleeding events. Although it seems that patients with CBD have lower mortality rates, further studies are necessary to fully understand this, especially considering comorbidities and low number of available studies.<\/jats:p>","DOI":"10.1055\/s-0043-1775733","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:14:35Z","timestamp":1695856475000},"page":"552-568","source":"Crossref","is-referenced-by-count":2,"title":["Congenital Bleeding Disorders and COVID-19\u2014A Systematic Literature Review"],"prefix":"10.1055","volume":"50","author":[{"given":"Akbar","family":"Dorgalaleh","sequence":"additional","affiliation":[{"name":"Hamin Pazhuhan Tis Institute, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehrab","family":"Safdari","sequence":"additional","affiliation":[{"name":"Departments of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Tabibian","sequence":"additional","affiliation":[{"name":"Iranian Comprehensive Hemophilia Care Center, Blood and Viral Research Center, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Shams","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dabbagh","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Anesthesia Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Rezazadeh","sequence":"additional","affiliation":[{"name":"Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"1951291","DOI":"10.1080\/15321819.2021.1951291","article-title":"COVID-19: clinical presentation and detection methods","volume":"43","author":"M Pradhan","year":"2022","journal-title":"J Immunoassay Immunochem"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"e3377","DOI":"10.1002\/dmrr.3377","article-title":"Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)","volume":"37","author":"Y Zhou","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"A C Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"S Schulman","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MBC.0000000000001019","article-title":"Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019","volume":"32","author":"A Dorgalaleh","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref6","first-page":"1","article-title":"Medical and socio-psychological consequences of the COVID-19 pandemic on people with congenital bleeding disorders and their caregivers","volume":"2","author":"H KB Z\u00fclfikar","year":"2023","journal-title":"CJN"},{"issue":"07","key":"ref7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/s-0040-1713435","article-title":"Patients with congenital bleeding disorders appear to be less severely affected by SARS-CoV-2: is inherited hypocoagulability overcoming acquired hypercoagulability of coronavirus disease 2019 (COVID-19)?","volume":"46","author":"A Dorgalaleh","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/hae.14089","article-title":"Registry of patients with congenital bleeding disorders and COVID-19 in Madrid","volume":"26","author":"M T \u00c1lvarez Rom\u00e1n","year":"2020","journal-title":"Haemophilia"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.dsx.2020.07.005","article-title":"Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: a systematic review","volume":"14","author":"N Zaki","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1039\/D0MO00189A","article-title":"A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19","volume":"17","author":"D Barh","year":"2021","journal-title":"Mol Omics"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1710018","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","volume":"120","author":"L Spiezia","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/ijlh.13413","article-title":"Do congenital bleeding disorders have a protective effect against COVID-19? A prospective study","volume":"43","author":"A Dorgalaleh","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1111\/hae.14331","article-title":"Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: the Italian MECCOVID-19 study","volume":"27","author":"A Coluccia","year":"2021","journal-title":"Haemophilia"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jtha.2023.04.040","article-title":"COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry","volume":"22","author":"A Sharathkumar","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref15","first-page":"32","article-title":"COVID-19 experience with inherited bleeding disorders similar to the country population","volume":"28","author":"B Koc","year":"2022","journal-title":"Haemophilia"},{"key":"ref16","first-page":"14","article-title":"The effects of coronavirus disease 2019 pandemic on patients with hemophilia and inherited bleeding disorders: results from 2 centers in Turkey. Age (years, mean\u2009\u00b1\u2009SD)","volume":"28","author":"D G G\u00f6k\u00e7ebay","year":"2023","journal-title":"Turk Pediatri Ars"},{"key":"ref17","first-page":"51","article-title":"Characterization of inherited coagulation disorders patients and COVID-19 infection in COLOMBIA","volume":"27","author":"I Perdomo-Amar","year":"2021","journal-title":"Haemophilia"},{"key":"ref18","first-page":"161","article-title":"Patients with congenital bleeding disorders and COVID-19: from one center in Algiers, Algeria","volume":"27","author":"N Ferroudj","year":"2021","journal-title":"Haemophilia"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/hae.14761","article-title":"Prevalence of COVID-19 related hospitalizations and mortality in adults aged \u226540 years with haemophilia: a survey from Europe","volume":"29","author":"C Hermans","year":"2023","journal-title":"Haemophilia"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.35754\/0234-5730-2023-68-2-219-228","article-title":"COVID-19 in patients with congenital bleeding disorders in Russia","volume":"68","author":"E V Yakovleva","year":"2023","journal-title":"Gematol Transfuziol"},{"key":"ref24","first-page":"40","article-title":"Development of factor inhibitors in congenital haemophilia patients after following COVID-19 vaccination. A Health Center experience","volume":"28","author":"V Arrieta","year":"2022","journal-title":"Haemophilia"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.52142\/omujecm.39.3.33","article-title":"The practice of COVID-19 vaccination in patients bleeding disorders","volume":"39","author":"M H Atay","year":"2022","journal-title":"J Exp Clin Med"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/hae.14586","article-title":"Safety of intramuscular COVID-19 vaccination in patients with haemophilia","volume":"28","author":"A Tiede","year":"2022","journal-title":"Haemophilia"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12879-022-07411-5","article-title":"Adverse effects following COVID-19 vaccination in Iran","volume":"22","author":"E Babaee","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1002\/jmv.27214","article-title":"Safety of COVID-19 vaccines","volume":"93","author":"Q A Al Khames Aga","year":"2021","journal-title":"J Med Virol"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1871529X22666220614090005","article-title":"Congenital bleeding disorders and COVID-19 - an emphasis on the role of thrombosis as one of the main causes of morbidity and mortality in COVID-19","volume":"22","author":"A Dorgalaleh","year":"2022","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11239-006-5732-0","article-title":"Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature","volume":"21","author":"A Girolami","year":"2006","journal-title":"J Thromb Thrombolysis"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1111\/ijlh.13318","article-title":"Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency and COVID-19-A common clinical feature between a rare disorder and a new, common infection","volume":"42","author":"A Dorgalaleh","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1111\/hae.14088","article-title":"Severe bleeding in a patient with factor XIII deficiency and COVID-19","volume":"27","author":"G Quintavalle","year":"2021","journal-title":"Haemophilia"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000510591","article-title":"Management of COVID-19 coagulopathy in a patient with severe haemophilia A","volume":"144","author":"J Pinto Pereira","year":"2021","journal-title":"Acta Haematol"},{"issue":"02","key":"ref38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/hematolrep14020015","article-title":"Severe COVID-19 infection management in a patient with mild haemophilia-a case report","volume":"14","author":"S An\u017eej Doma","year":"2022","journal-title":"Hematol Rep"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"00537","DOI":"10.2106\/JBJS.CC.20.00537","article-title":"COVID-19 infection after a total knee arthroplasty in a patient with hemophilia a: a case report","volume":"10","author":"Y L Taranchenko","year":"2020","journal-title":"JBJS Case Connect"},{"issue":"04","key":"ref40","first-page":"e214","article-title":"Clinical findings in a patient with haemophilia A affected by COVID-19","volume":"26","author":"D Cui","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11239-020-02227-z","article-title":"How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report","volume":"50","author":"E Zanon","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"09","key":"ref42","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/jth.14954","article-title":"Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis","volume":"18","author":"M I Rivas-Pollmar","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/ijlh.13385","article-title":"Persistent hiccups in a patient with mild congenital factor V deficiency and COVID-19; clinical and laboratory finding of a rare bleeding disorder","volume":"43","author":"A Dorgalaleh","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"e28662","DOI":"10.1002\/pbc.28662","article-title":"COVID-19 in a pediatric patient with Glanzmann thrombasthenia","volume":"67","author":"L Sattler","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"ref45","first-page":"140","article-title":"COVID-19 in von Willebrand disease type 3 child","volume":"27","author":"R Tarawah","year":"2021","journal-title":"Haemophilia"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12887-022-03463-3","article-title":"Multisystem inflammatory syndrome in a neonate with severe hemophilia - a diagnostic challenge in COVID times: a case report","volume":"22","author":"S Arun","year":"2022","journal-title":"BMC Pediatr"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1111\/hae.14252","article-title":"Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection","volume":"27","author":"A Vagrecha","year":"2021","journal-title":"Haemophilia"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1111\/hae.14326","article-title":"Successful treatment of COVID-19 in a patient with severe haemophilia A on emicizumab prophylaxis in the intensive care unit","volume":"27","author":"D Urbaniak-Kujda","year":"2021","journal-title":"Haemophilia"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1775733.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:13:17Z","timestamp":1730826797000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1775733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":41,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,5,20]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1775733","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}